From KCRW, I'm Kim Masters, and this is The Business.

This week, we bring you a look at what's going on in TV land.

First, we check in with the Hollywood Reporter's Awards analysts, Scott Feinberg, about what to make of this year's Emmy nominations.

You've got a lot of new blood like Shogun, which was originally a limited series that's been converted to a drama series because the drama series category looked so weak.

So it's a weird thing going on with the drama series category for sure.

And our frequent contributor, Eric Deggans, tells us about the Television Critics Association's

recently concluded summer press tour.

An event that used to involve two packed weeks of Q&A sessions with talent and executives

was down to eight days in these hard times in Hollywood.

I talked to a few writers who were pitching projects around town, and they were

suspicious that development executives were meeting with them just to say that they met,

and that it was obvious to everybody in the room that they weren't really going to buy anything

yet. Eric explains why so many in the industry are using the mantra, survive until 2025.

But first we banter. Stick around. It's the business from KCRW.

I am joined by my associate in banter, Matt Bellany. Hello, Matt. Hi there. So quite

recently, HBO announced that they had signed up the key talent from their hit show, Euphoria,

and they were going to go into production at the beginning of January 2025.

I will note that the last episode of Euphoria that aired was in February of 2022, and there's

been a lot of behind-the-scenes drama. And as we both know, I was working on a rather

extensive story about what was going on backstage with Euphoria. And I have to feel like

that announcement was like counter- counter programming before my story published.

That's probably true. But, you know, the interesting thing is, why is HBO bothering with this

...